pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

15,048 catalysts · 3,603 8k filing · 2,723 grant · 2,426 approval · 1,714 device 510k · 1,264 device recall · 1,172 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-09-29×clear all
type
  • 8k filing3,603
  • grant2,723
  • approval2,426
  • device 510k1,714
  • device recall1,264
  • device pma1,172
  • device adverse event1,000
  • earnings585
  • recall481
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Dec 15, 2025

    50
    ›Dec 15, 2025approval258d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 15, 2025approval258d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 15, 2025approval258d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalAurobindo Pharma Ltd

    Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2025approval258d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2025approval258d agoNALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approvalLupin Ltd

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2025approval258d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 15, 2025approval258d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalAurobindo Pharma Ltd

    Sponsor: SUN PHARM INDS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2025approval258d agoTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 15, 2025approval258d agoNALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approvalLupin Ltd

    Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2025approval258d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 15, 2025approval258d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

    Sponsor: SUN PHARM INDS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2025approval258d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Dec 15, 2025approval258d agoCLARISCAN (GADOTERATE MEGLUMINE) — FDA approvalCLARISCAN

    Sponsor: GE HEALTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →CLARISCAN →fda approvals ↗
    ›Dec 15, 2025approval258d agoCLARISCAN (GADOTERATE MEGLUMINE) — FDA approvalCLARISCAN

    Sponsor: GE HEALTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →CLARISCAN →fda approvals ↗
    ›Dec 15, 2025approval258d agoCLARISCAN (GADOTERATE MEGLUMINE) — FDA approvalCLARISCAN

    Sponsor: GE HEALTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →CLARISCAN →fda approvals ↗
    ›Dec 15, 2025approval258d agoCLARISCAN (GADOTERATE MEGLUMINE) — FDA approvalCLARISCAN

    Sponsor: GE HEALTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →CLARISCAN →fda approvals ↗
    ›Dec 15, 2025approval258d agoNILOTINIB — FDA approvalNILOTINIB

    Sponsor: TORRENT. Form: CAPSULE

    full page →NILOTINIB →fda approvals ↗
    ›Dec 15, 2025approval258d agoBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalBUPRENORPHINE HYDROCHLORIDE

    Sponsor: ASCENT PHARMS INC. Form: TABLET. Route: SUBLINGUAL

    full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗
    ›Dec 15, 2025approval258d agoENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvaltrastuzumab deruxtecan

    Sponsor: DAIICHI SANKYO. Form: INJECTABLE. Route: INJECTION

    full page →trastuzumab deruxtecan →fda approvals ↗
    ›Dec 15, 2025approval258d agoENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvaltrastuzumab deruxtecan

    Sponsor: DAIICHI SANKYO. Form: INJECTABLE. Route: INJECTION

    full page →trastuzumab deruxtecan →fda approvals ↗
    ›Dec 15, 2025approval258d agoPEMETREXED DISODIUM — FDA approvalAlimta

    Sponsor: SANDOZ. Form: SOLUTION. Route: INTRAVENOUS

    full page →Alimta →fda approvals ↗
    ›Dec 15, 2025approval258d agoSULFAMETHOPRIM-DS (SULFAMETHOXAZOLE) — FDA approval

    Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2025approval258d agoSULFAMETHOPRIM-DS (SULFAMETHOXAZOLE) — FDA approval

    Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2025device 510k258d agoProprio, Inc. — Paradigm System (510k cleared)

    Product code: OLO. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoSpectrawave, Inc. — HyperVue™ Imaging System - Integrated (510k cleared)

    Product code: NQQ. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoInstylla, Inc. — Tembo Embolic System (510k cleared)

    Product code: KRD. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoHowmedica Osteonics Corp., Dba Stryker Orthopaedics — Triathlon® Tritanium® Asymmetric Patella; Triathlon® Tritanium® Symmetric Patella; Triathlon® Symmetric Patella; Triathlon® Asymmetric Patella; Scorpio® Universal Dome Patella; Triathlon® Hinge Bumper (510k cleared)

    Product code: KRO. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoFoshan Pingchuang Medical Technology Co., Ltd. — Hybrid personal lubricant (water&silicone) (5ml, 8ml, 10ml, 12ml, 15ml, 20ml, 30ml, 50ml, 60ml, 75ml, 90ml, 100ml, 120ml, 150ml, 180ml, 200ml, 250ml, 300ml, 500ml) (510k cleared)

    Product code: NUC. Advisory committee: Obstetrics/Gynecology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoFemasys, Inc. — FemVue® Controlled Saline-Air Device (FSA-300) (510k cleared)FEMASYS INC

    Product code: LKF. Advisory committee: Obstetrics/Gynecology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoSpineology, Inc. — OptiMesh Multiplanar Expandable Interbody Fusion System (510k cleared)

    Product code: OQB. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoIntuitive Surgical, Inc. — da Vinci SP Surgical System (SP1098) (510k cleared)INTUITIVE SURGICAL INC

    Product code: NAY. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoMachina Medical, Inc. — MFUSE (MS001) (510k cleared)

    Product code: QSY. Advisory committee: Unknown. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoArgon Medical Devices, Inc. — V•Stick™ Vascular Access Set (510k cleared)

    Product code: DYB. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoSleepres, Inc. — SleepRes PAP System (510k cleared)

    Product code: BZD. Advisory committee: Anesthesiology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device 510k258d agoErchonia Corporation — Erchonia CLX (Model # CFL) (510k cleared)

    Product code: OLI. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 15, 2025device pma258d agoVentana Medical Systems, Inc. — PATHWAY anti- HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody (PMA supplement)MERIT MEDICAL SYSTEMS INC

    Supplement type: Normal 180 Day Track. Product code: MVC. Advisory committee: PA. Decision: APPR

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoMedtronic Cardiac Rhythm Disease Management — Amplia MRI CRT-D; Amplia MRI Quad CRT-D; Brava CRT-D; Brava Quad CRT-D; Claria MRI CRT-D; Claria MRI Quad CRT-D; Cobalt (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIK. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoEBR Systems, Inc. — WiSE® (Wireless Stimulation of the Endocardium Technology) CRT System (PMA supplement)EBR Systems, Inc.

    Supplement type: 30-Day Notice. Product code: SEG. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoDepuy, Inc. — LCS Total Knee System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NJL. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoBoston Scientific Corp — WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device with Delivery System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Normal 180 Day Track No User Fee. Product code: NGV. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoUrotronic, Inc. — Optilume™ BPH Catheter System (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: QXB. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoBoston Scientific Corp — WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device with Delivery System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Normal 180 Day Track No User Fee. Product code: NGV. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoETHICON, Inc. — ETHIZIA (PMA)

    Product code: SGV. Advisory committee: SU. Decision: APPR

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoVentana Medical Systems, Inc. — HER2 Dual ISH DNA Probe Cocktail (PMA supplement)MERIT MEDICAL SYSTEMS INC

    Supplement type: Normal 180 Day Track. Product code: NYQ. Advisory committee: PA. Decision: APPR

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoMedibeacon, Inc. — MediBeacon® Transdermal GFR Measurement System (TGFR) (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: SDK. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoMedtronic, Inc. — Aurora EV-ICD System (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoScibase AB — Nevisense (PMA supplement)

    Supplement type: 30-Day Notice. Product code: ONV. Advisory committee: SU. Decision: OK30

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoMedtronic Cardiac Rhythm Disease Management — Cobalt MRI ICD DDPB3D4, DVPB3D4; Cobalt XT MRI ICD DDPA2D4, DVPA2D4; Crome MRI ICD DDPC3D4, DVPC3D4; Evera MRI DF-1 ICD (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Dec 15, 2025device pma258d agoRoche Molecular Systems, Inc. — COBAS HPV TEST (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MAQ. Advisory committee: MI. Decision: OK30

    full page →fda device pma ↗
    ›Dec 15, 2025device recall258d agoImmunotech A.S. device recall (Cls II)AIM ImmunoTech Inc.

    Estrone RIA, REF: DSL8700 — Reason: The affected Estrone RIA kit lots may rarely give falsely high patient results which might cause Temporary injury of Remote probability. Only in some (very rare) cases may the issue occur. — Status: Ongoing

    full page →fda device recalls ↗
    ← prev
    page 65 of 301
    next →
    $MMSI90.49+1.06%
    $ISRG372.60+1.51%
    $FEMY
    $AMRX17.54-2.61%
    $HCA417.82-0.36%
    $HCA417.82-0.36%
    $HCA417.82-0.36%
    $BSX46.84+0.36%
    $HCA417.82-0.36%
    $EBRCZ0.2780+48.56%
    $MMSI90.49+1.06%
    $BSX46.84+0.36%
    $MDT91.23+1.40%
    $AIM